Abstract
The early diagnosis of urothelial cancer allows for effective local treatment and optimizes the success of surgical therapy. Nuclear matrix protein 22 (NMP22), Basic fetoprotein (BFP) and Bladder tumor antigen (BTA) were introduced for the detection of transitional cell carcinoma. The objective of this study was to determine whether there was a correlation between urine NMP22, BFP, BTA and the grade or stage of urothelial cancer, and whether they could serve as a biochemical markers of urothelial cancer.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
